from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1511/gmdA

LFCtreatmentdescriptionclass of inhibitor

2.446

Amikacinug/mL Amikacintranslation

3.590

Cap5-10ug/mL Capreomycintranslation

3.624

Rox10-50 ug/mL Roxithromycintranslation

2.598

SM2-5 ug/mL Streptomycintranslation

3.884

Tet5-10 ug/mL Tetracyclinetranslation

-0.281

Rif0.2-5ug/mL Rifampicintranscription

-0.919

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.109

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.352

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.330

CPZ10-50 ug/mL Chlorpromazinerespiration

0.088

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.023

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.169

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.122

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.381

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.172

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.673

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.632

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.102

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.055

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.053

KCN5-20 ug/mL Potassium cyaniderespiration

-0.357

NaN30.2-2 mM Sodium aziderespiration

0.068

Nigericin50 uM Nigericinrespiration

-1.115

TRC10-150 ug/mL Triclosanrespiration

0.444

TRZ10-25 ug/mL Thioridazinerespiration

-0.426

Valinomycin0.5-10 uM Valinomycinrespiration

0.625

ZnSO42 mM ZnSO4respiration

0.148

menadione6-10 ug/mL Menadionerespiration

0.003

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.106

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.261

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.302

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.296

NRP_1Non-replicating persistence stage 1dosRassociated

0.470

Amp0.2mg/mL AmpicillincellWall

-0.250

Cephalexin20-100 ug/mL CephalexincellWall

0.725

Cerulenin0.32-5 ug/mL CerulenincellWall

0.147

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.213

EMB10-20 ug/mL EthambutolcellWall

0.079

Eta12-40 ug/mL EthionamidecellWall

0.121

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.131

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.010

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.370

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.591

BZA0.12 mg/mL BenzamidearomaticAmides

-0.675

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.205

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.001

H2O24 mM hydrogen peroxideDNAdamaging

0.285

Levo10 ug/mL LevofloxacinDNAdamaging

0.071

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.119

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.419

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.130

UVUV-irradiationDNAdamaging

0.709

ARP41-4 ug/mL Antitubercular compound ARP4?

0.127

Antimycin12.5-50 ug/mL Antimycin A?

0.027

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.458

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.356

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.004

PA8240.2-2 ug/mL PA-824?

-0.521

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.097

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.094

Verapamil50 uM Verapamil?

-0.061

mercaptoethanol2 mM 2-Mercaptoethanol?

0.130

methoxatin10-20 ug/mL Methoxatin?